MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Risk of Parkinson’s in idiopathic anosmia

R. Rees, S. Gane, C. Philpott, A. Noyce, A. Schrag (Norwich, United Kingdom)

Meeting: 2019 International Congress

Abstract Number: 1045

Keywords: Aging, Parkinsonism

Session Information

Date: Tuesday, September 24, 2019

Session Title: Parkinsonisms and Parkinson-Plus

Session Time: 1:45pm-3:15pm

Location: Agora 3 West, Level 3

Objective: To identify markers of increased risk of Parkinson’s in a cohort of individuals with idiopathic anosmia

Background: Smell loss (anosmia) is a common finding in people with Parkinson’s disease (PD), although it is also quite common in older age. Population studies assessing the prodromal phase of Parkinson’s have therefore included individuals with smell loss. However, the differential diagnosis of anosmia is broad, and it’s likely that only a subset are linked to neurodegeneration.

Method: We assessed neurologically healthy patients aged 60-80y from two specialist ENT clinics (James Paget Hospital, Norfolk; RNTNE, London). All participants had a diagnosis of idiopathic anosmia after comprehensive investigation, including objective smell testing, nasendoscopy, and cross-sectional imaging. Participants completed online PREDICT-PD testing (www.predictpd.com) followed by an in-person assessment with standardised physical (MDS-UPDRS, timed up and go, handwriting), cognitive (Montreal Cognitive Assessment, verbal fluency) and autonomic (postural blood pressure, SCOPA-AUT) and other assessments.

Results: We recruited 24 participants (M:F 42:58%), mean age 71.1y (SD 3.8y). Participants had a mean of 14.4 years of education (SD 3.1). Adjusted MoCA scores had a median of 26.5/30 (IQR 24.75-28.0). There was a range of subtle motor impairment, median UPDRS III 4.5 (IQR 1.75-8.0, max 20) and median 3m up-&-go time 8.35s (IQR 7.8-9.3, max 13s). Although autonomic function, assessed by the SCOPA-AUT, appears in the normal range (mean 8.7, SD 6.7), there were several participants severely affected.

Conclusion: This is the first UK-based prospective study of individuals with idiopathic anosmia assessing prodromal Parkinsonian features. There is subtle cognitive and motor impairment, although autonomic function does not seem to be severely affected.

To cite this abstract in AMA style:

R. Rees, S. Gane, C. Philpott, A. Noyce, A. Schrag. Risk of Parkinson’s in idiopathic anosmia [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/risk-of-parkinsons-in-idiopathic-anosmia/. Accessed June 17, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/risk-of-parkinsons-in-idiopathic-anosmia/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • #25062 (not found)
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley